ZENTALIS PHARMACEUTICALS INC's ticker is ZNTL and the CUSIP is 98943L107. A total of 139 filers reported holding ZENTALIS PHARMACEUTICALS INC in Q1 2024. The put-call ratio across all filers is 0.03 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $12,484,283 | -79.1% | 3,052,392 | -19.4% | 0.00% | -66.7% |
Q1 2024 | $59,661,876 | -10.8% | 3,785,652 | -14.3% | 0.00% | 0.0% |
Q4 2023 | $66,918,398 | +23.4% | 4,417,056 | +63.4% | 0.00% | 0.0% |
Q3 2023 | $54,229,402 | -39.0% | 2,703,360 | -14.3% | 0.00% | -40.0% |
Q2 2023 | $88,943,704 | +82.6% | 3,152,914 | +11.3% | 0.01% | +66.7% |
Q1 2023 | $48,710,796 | -60.8% | 2,832,023 | -54.1% | 0.00% | -25.0% |
Q4 2022 | $124,229,038 | +101.2% | 6,168,274 | +116.4% | 0.00% | 0.0% |
Q3 2022 | $61,735,000 | -29.6% | 2,850,174 | -8.6% | 0.00% | -20.0% |
Q2 2022 | $87,665,000 | -8.7% | 3,119,734 | +50.0% | 0.01% | 0.0% |
Q1 2022 | $95,992,000 | -15.2% | 2,080,440 | +54.5% | 0.01% | 0.0% |
Q4 2021 | $113,180,000 | +31.4% | 1,346,416 | +4.2% | 0.01% | 0.0% |
Q3 2021 | $86,116,000 | +20.9% | 1,292,263 | -3.5% | 0.01% | +25.0% |
Q2 2021 | $71,253,000 | +11.8% | 1,339,340 | -8.8% | 0.00% | 0.0% |
Q1 2021 | $63,748,000 | +37.7% | 1,469,191 | +64.8% | 0.00% | +33.3% |
Q4 2020 | $46,305,000 | +776.5% | 891,509 | +451.7% | 0.00% | – |
Q3 2020 | $5,283,000 | -19.9% | 161,594 | +17.7% | 0.00% | – |
Q2 2020 | $6,592,000 | – | 137,270 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Mayo Clinic | 187,143 | $765,415 | 25.27% |
Decheng Capital LLC | 3,070,442 | $12,558,107 | 3.85% |
MPM BioImpact LLC | 1,450,000 | $5,930,500 | 0.92% |
TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 961,486 | $3,932,478 | 0.80% |
Eventide Asset Management | 8,547,896 | $34,960,895 | 0.60% |
5AM Venture Management, LLC | 490,000 | $2,004,100 | 0.45% |
Matrix Capital Management Company, LP | 13,959,973 | $57,096,290 | 0.44% |
Values First Advisors, Inc. | 74,925 | $306,443 | 0.18% |
Boxer Capital, LLC | 450,000 | $1,840,500 | 0.10% |
GSA CAPITAL PARTNERS LLP | 255,201 | $1,044 | 0.07% |